Basel, Switzerland, 22 March 2016 – Lonza today announced that it has published its Annual Report 2015 and its invitation to the Annual General Meeting 2016, which will take place on Friday, 22 April 2016, at 10:00 a.m. CEST, at the Congress Center Messe Basel, Messeplatz 21, 4058 Basel, Switzerland.
The Annual Report is available on the following link as of today, where an interactive version and a PDF of the Annual Report can be accessed: www.lonza.com/financial-reports. Copies of the Annual Report can also be ordered from that link.
This year’s Annual General Meeting invitation can be accessed on Lonza’s website by clicking on “Annual General Meeting 2016” on the following webpage: www.lonza.com/about-lonza/investor-relations/investor-information
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
